MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/aas.13957

Медицинская библиотека · Acta anaesthesiologica Scandinavica · 2021

A blinded randomized study comparing intubating conditions after either rocuronium 0.6 mg·kg-1 or remifentanil 2 µg·kg-1 in elderly patients.

Vested Matias, Sørensen Anne Marie, Bjerring Cecilie, Christensen Rasmus E, Dinesen Felicia, Vang Malene, Gilvanoff Alexander, Hansen Thea Ellehammer, Nielsen Tatiana, Rasmussen Lars S

СтатьяРандомизированное исследованиеПеревод в очереди

Аннотация

BACKGROUND

To facilitate tracheal intubation, either a neuromuscular blocking agent or a bolus dose of remifentanil can be administered. We hypothesized that rocuronium 0.6 mg·kg-1 provided a larger proportion of excellent intubating conditions compared to remifentanil 2 µg·kg-1 in patients above 80 years.

METHODS

A total of 78 patients were randomized to either rocuronium 0.6 mg·kg-1 or remifentanil 2 µg·kg-1 . General anaesthesia was initiated with fentanyl and propofol. Two minutes after the administration of either rocuronium or remifentanil, tracheal intubating conditions were evaluated using the Fuchs-Buder scale by a blinded investigator, and our primary outcome was the proportion of patients presenting intubating conditions deemed as excellent. Further outcomes included the Intubating Difficulty Scale (IDS), hoarseness or sore throat 24 h postoperatively, and intervention against hypotension.

RESULTS

No difference in the occurrence of excellent intubating conditions was found comparing the rocuronium group with the remifentanil group; 10 (28%) versus 15 (39%) (p = .29), respectively, relative risk = 0.72. Interventions against hypotension were used in 24 (67%) versus 28 (74%) (p = .51), respectively. Hoarseness and sore throat 24 h postoperatively were found in 37% versus 35% p = .86, and 14% versus 5% p = .20, respectively. The IDS score was 2 versus 2 p = .48.

CONCLUSION

No difference in intubating conditions was found 2 min after the administration of either rocuronium 0.6 mg·kg-1 or remifentanil 2 µg·kg-1 in patients aged above 80 years. Intubation conditions were less than optimal in a large proportion of this patient population.

CLINICAL TRIALS REGISTRATION: NCT04287426.

Для цитирования: Vested Matias, Sørensen Anne Marie, Bjerring Cecilie, Christensen Rasmus E, Dinesen Felicia, Vang Malene, Gilvanoff Alexander, Hansen Thea Ellehammer, Nielsen Tatiana, Rasmussen Lars S. A blinded randomized study comparing intubating conditions after either rocuronium 0.6 mg·kg-1 or remifentanil 2 µg·kg-1 in elderly patients.. Acta anaesthesiologica Scandinavica. 2021. DOI: 10.1111/aas.13957.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.